Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines and/or [1,2,4]triazolo[1,5-c]pteridines for treatment of central nervous system diseases and disorders

Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines and/or [1,2,4]triazolo[1,5-c]pteridines for treatment of central nervous system diseases and disorders

US Patent 9284335 · Granted Mar 15, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline forms of a MAGL inhibitor2025
Crystalline forms of a MAGL inhibitor2024
Compounds and methods for modulating HER22024
Substituted furanopyrimidine compounds as PDE1 inhibitors2024
Substituted furanopyrimidine compounds as PDE1 inhibitors2024
Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors2024
Substituted cyclohexyl compounds as NOP inhibitors2024
Compounds that modulate intracellular calcium2024
MAGL inhibitors2022
Substituted furanopyrimidine compounds as PDE1 inhibitors2022
Substituted furanopyrimidine compounds as PDE1 inhibitors2022
Substituted cyclohexyl compounds as NOP inhibiiors2022